HomeCompareFB vs ABBV

FB vs ABBV: Dividend Comparison 2026

FB yields 1.30% · ABBV yields 3.67%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ABBV wins by $17.7K in total portfolio value
10 years
FB
FB
● Live price
1.30%
Share price
$42.38
Annual div
$0.55
5Y div CAGR
5.5%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$22.2K
Annual income
$247.06
Full FB calculator →
ABBV
AbbVie Inc.
● Live price
3.67%
Share price
$168.90
Annual div
$6.20
5Y div CAGR
8.9%
Payout ratio
58%
After 10 yrs · $10,000 · DRIP
Portfolio value
$39.9K
Annual income
$1,154.43
Full ABBV calculator →

Portfolio growth — FB vs ABBV

📍 ABBV pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodFBABBV
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, FB + ABBV cover 4 of 12 monthsgood coverage

Jan
ABBV
Feb
Mar
Apr
ABBV
May
Jun
Jul
ABBV
Aug
Sep
Oct
ABBV
Nov
Dec
FB pays
ABBV pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

FB
Annual income on $10K today (after 15% tax)
$110.32/yr
After 10yr DRIP, annual income (after tax)
$210.00/yr
ABBV
Annual income on $10K today (after 15% tax)
$312.02/yr
After 10yr DRIP, annual income (after tax)
$981.27/yr
At 15% tax rate, ABBV beats the other by $771.26/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of FB + ABBV for your $10,000?

FB: 50%ABBV: 50%
100% ABBV50/50100% FB
Portfolio after 10yr
$31.0K
Annual income
$700.75/yr
Blended yield
2.26%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on ABBV right now

FB
No analyst data
Altman Z
1.8
Piotroski
6/9
ABBV
Analyst Ratings
27
Buy
12
Hold
1
Sell
Consensus: Buy
Price Target
$256.15
+51.7% upside vs current
Range: $223.00 — $299.00
Altman Z
2.0
Piotroski
8/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

FB buys
0
ABBV buys
0
No recent congressional trades found for FB or ABBV in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricFBABBV
Forward yield1.30%3.67%
Annual dividend / share$0.55$6.20
Payout ratio50%58%
1-year div growth0%4.7%
5-year div CAGR5.5%8.9%
Portfolio after 10y$22.2K$39.9K
Annual income after 10y$247.06$1,154.43
Total dividends collected$1.9K$7.2K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: FB vs ABBV ($10,000, DRIP)

YearFB PortfolioFB Income/yrABBV PortfolioABBV Income/yrGap
1← crossover$10,837$136.93$11,520$399.75$683.00ABBV
2$11,742$146.31$13,261$450.98$1.5KABBV
3$12,720$156.31$15,255$508.41$2.5KABBV
4$13,777$166.95$17,536$572.74$3.8KABBV
5$14,920$178.30$20,145$644.78$5.2KABBV
6$16,155$190.38$23,126$725.38$7.0KABBV
7$17,489$203.24$26,532$815.52$9.0KABBV
8$18,930$216.94$30,420$916.26$11.5KABBV
9$20,487$231.53$34,855$1,028.80$14.4KABBV
10$22,168$247.06$39,914$1,154.43$17.7KABBV

FB vs ABBV: Complete Analysis 2026

FBStock

The index measures the performance of this Dynamic Buffer Strategy based on the S&P 500 Index using a long position in the S&P 500 Index along with three different S&P 500 Index options that have one day to expiration. Under normal circumstances, the fund will invest at least 80% of its total assets in components of the index or in instruments with similar economic characteristics. The fund is non-diversified.

Full FB Calculator →

ABBVHealthcare

AbbVie is a pharmaceutical giant best known for Humira and newer blockbusters Skyrizi and Rinvoq. A Dividend Aristocrat with 52+ years of consecutive dividend increases. Strong free cash flow generation supports its above-average yield. The company's diversified pipeline reduces dependence on any single drug.

Full ABBV Calculator →
📬

Get this FB vs ABBV comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

FB vs SCHDFB vs JEPIFB vs OFB vs KOFB vs MAINFB vs JNJFB vs MRKFB vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.